PMID- 19682619 OWN - NLM STAT- MEDLINE DCOM- 20091105 LR - 20111117 IS - 1873-2518 (Electronic) IS - 0264-410X (Linking) VI - 27 IP - 43 DP - 2009 Oct 9 TI - Hepatitis B vaccination failure in celiac disease: is there a need to reassess current immunization strategies? PG - 6030-3 LID - 10.1016/j.vaccine.2009.07.099 [doi] AB - Human leukocyte antigen (HLA) phenotype DQ2 is considered the most important genetic marker for un-responsiveness to hepatitis B vaccine. Since celiac disease (CD) is also strongly associated with the same haplo-type it may be hypothesized that celiac patients are less able to respond to the vaccine. We report a retrospective study on celiac patients vaccinated with three doses of 10 microg at 3, 5 and 11 months of age by an intramuscular injection of a recombinant hepatitis B vaccine (Engerix B). We found 30 of 60 celiac patients (50%) unresponsive to vaccination and a significant higher number of responders among patients younger than 18 months at the time of celiac disease diagnosis. Our study confirms that celiac patients have a lower percentage of response to hepatitis B vaccination than healthy subjects. These findings provide useful information to evaluate if current vaccine strategies should be reassessed and if revaccination should be recommended. FAU - Leonardi, S AU - Leonardi S AD - Broncho-Pneumology & Cystic Fibrosis Unit, Department of Pediatrics, University of Catania, Catania, Italy. leonardi@unict.it FAU - Spina, M AU - Spina M FAU - Spicuzza, L AU - Spicuzza L FAU - Rotolo, N AU - Rotolo N FAU - La Rosa, M AU - La Rosa M LA - eng PT - Journal Article DEP - 20090812 PL - Netherlands TA - Vaccine JT - Vaccine JID - 8406899 RN - 0 (Engerix-B) RN - 0 (HLA-DQ Antigens) RN - 0 (HLA-DQ2 antigen) RN - 0 (Hepatitis Antibodies) RN - 0 (Hepatitis B Vaccines) RN - 0 (Vaccines, Synthetic) SB - IM MH - Celiac Disease/blood/genetics/*immunology MH - Female MH - HLA-DQ Antigens/genetics MH - Hepatitis Antibodies/*blood MH - Hepatitis B Vaccines/*immunology MH - Humans MH - Infant MH - Male MH - Retrospective Studies MH - Vaccination MH - Vaccines, Synthetic/immunology EDAT- 2009/08/18 09:00 MHDA- 2009/11/06 06:00 CRDT- 2009/08/18 09:00 PHST- 2009/03/23 00:00 [received] PHST- 2009/07/11 00:00 [revised] PHST- 2009/07/22 00:00 [accepted] PHST- 2009/08/18 09:00 [entrez] PHST- 2009/08/18 09:00 [pubmed] PHST- 2009/11/06 06:00 [medline] AID - S0264-410X(09)01111-6 [pii] AID - 10.1016/j.vaccine.2009.07.099 [doi] PST - ppublish SO - Vaccine. 2009 Oct 9;27(43):6030-3. doi: 10.1016/j.vaccine.2009.07.099. Epub 2009 Aug 12.